Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in Triple-Negative Breast Cancer Cells and Predicts Poor Prognosis

被引:26
|
作者
Liang, Hongguang [1 ]
Huang, Weihua [1 ]
Wang, Yuandong [1 ]
Ding, Lingying [2 ]
Zeng, Lixian [2 ]
机构
[1] Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Integrated Hosp Tradit Chinese Med, 13 Liugang Rd, Guangzhou 510315, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
triple-negative breast cancer; miR-146a-5p; lncRNA HOTAIR; prognosis; cancer cell migration; FEATURES;
D O I
10.1177/1533033819882949
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MiR-146a-5p plays different roles in different types of cancers. We showed that miR-146a-5p and long noncoding RNA HOTAIR were both upregulated in triple-negative breast cancer. Follow-up study showed that high levels of miR-146a-5p and HOTAIR in tumor tissues were closely correlated with poor survival. MiR-146a-5p and HOTAIR were positively correlated in tumor tissues. MiR-146a-5p positively regulated HOTAIR triple-negative breast cancer cells, while HOTAIR showed no regulatory effects on miR-146a-5p expression. MiR-146a-5p and HOTAIR positively regulated the migration and invasion of triple-negative breast cancer cells. In addition, HOTAIR silencing attenuated the effects of miR-146a-5p. Therefore, overexpression of miR-146a-5p may promote triple-negative breast cancer cell invasion and migration by upregulating HOTAIR.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] An Epithelial-Mesenchymal Transition-Related LncRNA Signature Predicts Prognosis in Triple-Negative Breast Cancer
    Chen, Xuezhang
    Chen, Xikang
    Zhu, Zhixia
    Chen, Yinsong
    Pang, Xiaoqi
    Zhong, Xianxun
    You, Shuang
    Chen, Yaoxu
    Tian, Huaqin
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02): : 1063 - 1073
  • [22] Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Kim, Min Chong
    Choi, Jung Eun
    Lee, Soo Jung
    Bae, Young Kyung
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3524 - 3530
  • [23] Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Min Chong Kim
    Jung Eun Choi
    Soo Jung Lee
    Young Kyung Bae
    Annals of Surgical Oncology, 2016, 23 : 3524 - 3530
  • [24] LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis
    Song, Xiang
    Liu, Zhaoyun
    Yu, Zhiyong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (04) : 386 - 392
  • [25] The oncogenic role of miR-150-5p in triple-negative breast cancer
    Sugita, Bruna M.
    Zabala, Yara
    Fonseca, Aline
    Almeida, Rodrigo
    Gusev, Yuriy
    Boca, Simina
    Cavalli, Iglenir J.
    Ribeiro, Enilze M.
    Cavalli, Luciane R.
    CANCER RESEARCH, 2017, 77
  • [26] CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer
    Wang, Hui
    Wang, Li
    Song, Ying
    Wang, Shuhuai
    Huang, Xu
    Xuan, Qijia
    Kang, Xinmei
    Zhang, Qingyuan
    ONCOLOGY LETTERS, 2017, 14 (05) : 5890 - 5898
  • [27] LncRNA AC093850.2 predicts poor outcomes in patients with triple-negative breast cancer and motivates tumor progression by sponging miR-4299
    Xu, Zhangbo
    Gu, Yongxue
    Lei, Ying
    Teng, Lili
    ACTA BIOCHIMICA POLONICA, 2023, : 83 - 89
  • [28] Overexpression of lncRNA SAMMSON Promotes Triple-Negative Breast Cancer Cell Proliferation by Interacting with p53
    Xing, Zeyu
    Zhang, Menglu
    Liu, Jiaqi
    Liu, Gang
    Feng, Kexin
    Wang, Xiang
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2021, 31 (06): : 1 - 8
  • [29] lncRNA LINC01315 promotes malignancy of triple-negative breast cancer and predicts poor outcomes by modulating microRNA-876-5p/GRK5
    Xiu, Yan
    Cao, Shannan
    Jiang, Ru
    Zhou, Yuming
    BIOENGINEERED, 2022, 13 (04) : 10001 - 10009
  • [30] Interleukin-34 contributes to poor prognosis in triple-negative breast cancer
    Nabeel Kajihara
    Fumihito Kitagawa
    Takuto Kobayashi
    Haruka Wada
    Ryo Otsuka
    Ken-ichiro Seino
    Breast Cancer, 2020, 27 : 1198 - 1204